101 related articles for article (PubMed ID: 12711451)
1. Poly(hydroxyethylaspartamide) derivatives as colloidal drug carrier systems.
Cavallaro G; Licciardi M; Giammona G; Caliceti P; Semenzato A; Salmaso S
J Control Release; 2003 Apr; 89(2):285-95. PubMed ID: 12711451
[TBL] [Abstract][Full Text] [Related]
2. Supramolecular association of recombinant human growth hormone with hydrophobized polyhydroxyethylaspartamides.
Salmaso S; Schrepfer R; Cavallaro G; Bersani S; Caboi F; Giammona G; Tonon G; Caliceti P
Eur J Pharm Biopharm; 2008 Mar; 68(3):656-66. PubMed ID: 17822889
[TBL] [Abstract][Full Text] [Related]
3. Polyhydroxyethylaspartamide-based micelles for ocular drug delivery.
Civiale C; Licciardi M; Cavallaro G; Giammona G; Mazzone MG
Int J Pharm; 2009 Aug; 378(1-2):177-86. PubMed ID: 19465101
[TBL] [Abstract][Full Text] [Related]
4. Amphiphilic poly(hydroxyethylaspartamide) derivative-based micelles as drug delivery systems for ferulic acid.
Craparo EF; Gennara C; Chiara OM; Girolamo T; Luisa BM; Gaetano G
J Drug Target; 2009 Jan; 17(1):78-88. PubMed ID: 19016108
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, physico-chemical and biological characterization of a paclitaxel macromolecular prodrug.
Cavallaro G; Licciardi M; Caliceti P; Salmaso S; Giammona G
Eur J Pharm Biopharm; 2004 Jul; 58(1):151-9. PubMed ID: 15207549
[TBL] [Abstract][Full Text] [Related]
6. PHEA-graft-polybutylmethacrylate copolymer microparticles for delivery of hydrophobic drugs.
Licciardi M; Di Stefano M; Craparo EF; Amato G; Fontana G; Cavallaro G; Giammona G
Int J Pharm; 2012 Aug; 433(1-2):16-24. PubMed ID: 22575755
[TBL] [Abstract][Full Text] [Related]
7. Nanoaggregates based on new poly-hydroxyethyl-aspartamide copolymers for oral insulin absorption.
Licciardi M; Pitarresi G; Cavallaro G; Giammona G
Mol Pharm; 2013 May; 10(5):1644-54. PubMed ID: 23331253
[TBL] [Abstract][Full Text] [Related]
8. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
9. PHEA-graft-polymethacrylate supramolecular aggregates for protein oral delivery.
Licciardi M; Pasut G; Amato G; Scialabba C; Mero A; Montopoli M; Cavallaro G; Schiavon O; Giammona G
Eur J Pharm Biopharm; 2013 May; 84(1):21-8. PubMed ID: 23275110
[TBL] [Abstract][Full Text] [Related]
10. Histidine-conjugated poly(amino acid) derivatives for the novel endosomolytic delivery carrier of doxorubicin.
Yang SR; Lee HJ; Kim JD
J Control Release; 2006 Aug; 114(1):60-8. PubMed ID: 16828916
[TBL] [Abstract][Full Text] [Related]
11. In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle.
Rezazadeh M; Emami J; Hasanzadeh F; Sadeghi H; Minaiyan M; Mostafavi A; Rostami M; Lavasanifar A
Drug Deliv; 2016 Jun; 23(5):1707-17. PubMed ID: 25188785
[TBL] [Abstract][Full Text] [Related]
12. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biopharmaceutical characterisation of new poly(hydroxyethylaspartamide) copolymers as drug carriers.
Caliceti P; Quarta SM; Veronese FM; Cavallaro G; Pedone E; Giammona G
Biochim Biophys Acta; 2001 Oct; 1528(2-3):177-86. PubMed ID: 11687305
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y
Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777
[TBL] [Abstract][Full Text] [Related]
15. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
[TBL] [Abstract][Full Text] [Related]
16. Phospholipid-polyaspartamide micelles for pulmonary delivery of corticosteroids.
Craparo EF; Teresi G; Bondi' ML; Licciardi M; Cavallaro G
Int J Pharm; 2011 Mar; 406(1-2):135-44. PubMed ID: 21185363
[TBL] [Abstract][Full Text] [Related]
17. Dendritic poly(ethylene glycol) bearing paclitaxel and alendronate for targeting bone neoplasms.
Clementi C; Miller K; Mero A; Satchi-Fainaro R; Pasut G
Mol Pharm; 2011 Aug; 8(4):1063-72. PubMed ID: 21608527
[TBL] [Abstract][Full Text] [Related]
18. PHEA-PLA biocompatible nanoparticles by technique of solvent evaporation from multiple emulsions.
Cavallaro G; Craparo EF; Sardo C; Lamberti G; Barba AA; Dalmoro A
Int J Pharm; 2015 Nov; 495(2):719-27. PubMed ID: 26410757
[TBL] [Abstract][Full Text] [Related]
19. Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel.
Danhier F; Magotteaux N; Ucakar B; Lecouturier N; Brewster M; Préat V
Eur J Pharm Biopharm; 2009 Oct; 73(2):230-8. PubMed ID: 19577643
[TBL] [Abstract][Full Text] [Related]
20. Design of polyaspartic acid peptide-poly (ethylene glycol)-poly (ε-caprolactone) nanoparticles as a carrier of hydrophobic drugs targeting cancer metastasized to bone.
Liu J; Zeng Y; Shi S; Xu L; Zhang H; Pathak JL; Pan Y
Int J Nanomedicine; 2017; 12():3561-3575. PubMed ID: 28507436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
